Clinical characteristics, risk factors and outcomes of cancer patients with COVID ‐19: A population‐based study

Author:

Zhou Jiandong1,Lakhani Ishan2ORCID,Chou Oscar3,Leung Keith Sai Kit4,Lee Teddy Tai Loy5,Wong Michelle Vangi2,Li Zhen6ORCID,Wai Abraham Ka Chung5,Chang Carlin7,Wong Ian Chi Kei89,Zhang Qingpeng1,Tse Gary21011ORCID,Cheung Bernard Man Yung12

Affiliation:

1. Nuffield Department of Medicine University of Oxford Oxford UK

2. Cardiovascular Analytics Group, Laboratory of Cardiovascular Physiology Hong Kong China

3. Li Ka Shing Faculty of Medicine University of Hong Kong Hong Kong China

4. Aston Medical School Aston University Birmingham UK

5. Emergency Medicine Unit University of Hong Kong Hong Kong China

6. Department of Radiology Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology Wuhan China

7. Division of Neurology, Department of Medicine University of Hong Kong Hong Kong China

8. Department of Pharmacology and Pharmacy University of Hong Kong Hong Kong China

9. Medicines Optimisation Research and Education (CMORE) UCL School of Pharmacy London UK

10. Tianjin Key Laboratory of Ionic‐Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology Second Hospital of Tianjin Medical University Tianjin China

11. Kent and Medway Medical School Canterbury Kent UK

12. Division of Clinical Pharmacology, Department of Medicine University of Hong Kong Hong Kong China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference33 articles.

1. Organization W.H.WHO COVID‐19 dashboard.202026 May 2021; Available from:https://covid19.who.int/

2. Determine the most common clinical symptoms in COVID‐19 patients: a systematic review and meta‐analysis;Alimohamadi Y;J Prev Med Hyg,2020

3. Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants

4. Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis

5. COVID-19 in cancer patients: risk, clinical features, and management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3